D. Reyes

发表

Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra‐arterial therapy using MR imaging‐based arterial enhancement fraction

Celia P. Corona-Villalobos, T. Pawlik, I. Kamel, 2014, Journal of magnetic resonance imaging : JMRI.

Title Quantitative and Volumetric EASL and RECIST : An Improved Method to Assess Tumor Response after Transcatheter Arterial Chemoembolization

R. Loffroy, B. Mory, R. Ardon, 2011 .

Phase II Study of Chemoembolization with Drug-eluting Beads in Patients with Hepatic Neuroendocrine Metastases: Interim Analysis

I. Kamel, D. Reyes, M. Bhagat, 2012 .

Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury

T. Pawlik, I. Kamel, MingDe Lin, 2013, CardioVascular and Interventional Radiology.

Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results.

T. Pawlik, I. Kamel, J. Geschwind, 2015, Radiology.

Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma: Initial Experience in the United States

M. Choti, I. Kamel, M. Torbenson, 2009, Cancer journal.

Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer

K. Pienta, B. Trock, A. Partin, 2022, Medical Oncology.

CT‐based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration‐naïve oligometastatic prostate cancer

K. Pienta, S. Sheikhbahaei, S. Rowe, 2020, The Prostate.

Complications of loco-regional therapy in the liver—spectrum of imaging findings by CT and MRI

E. Fishman, I. Kamel, D. Bonekamp, 2011, Emergency Radiology.

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

T. Pawlik, I. Kamel, N. Bhagat, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment

Jean L Wright, K. Pienta, D. Song, 2018, World Journal of Urology.

RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients

K. Pienta, Jun Luo, Wei Xue, 2022, Materials today. Bio.

The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.

D. Bluemke, I. Kamel, J. Geschwind, 2006, Journal of vascular and interventional radiology : JVIR.

The biology and treatment of oligometastatic cancer

K. Pienta, D. Reyes, 2015, Oncotarget.

Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

T. Pawlik, I. Kamel, M. Mulcahy, 2013, Cancer.

Experimental evaluation of a new transcatheter vascular embolization device in the swine model.

C. Magee, A. Venbrux, P. Brown, 2002, Journal of vascular and interventional radiology : JVIR.

Ten unanswered questions in cancer: "If this is true, what does it imply"?

K. Pienta, S. Glavaris, S. Amend, 2018, American journal of clinical and experimental urology.

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer

K. Pienta, P. Tran, C. Deville, 2020, Medical Oncology.

Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.

I. Kamel, C. Georgiades, K. Hong, 2009, Journal of vascular and interventional radiology : JVIR.

Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib

Celia P. Corona-Villalobos, T. Pawlik, I. Kamel, 2015, European Radiology.

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

David A Bluemke, Eleni Liapi, Marianna Zahurak, 2009, Radiology.

Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.

D. Bluemke, I. Kamel, J. Geschwind, 2007, Journal of vascular and interventional radiology : JVIR.

Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria.

Celia P. Corona-Villalobos, T. Pawlik, I. Kamel, 2013, Radiology.

Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy.

Celia P. Corona-Villalobos, T. Pawlik, I. Kamel, 2013, Radiology.

Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival.

John Eng, Jean-François Geschwind, Timothy M Pawlik, 2013, Radiology.

Peripheral androgen blockade in men with castrate-sensitive biochemical recurrent prostate cancer

K. Pienta, D. Reyes, 2021, Medical Oncology.

Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response.

Celia P. Corona-Villalobos, T. Pawlik, I. Kamel, 2012, Radiology.

Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer

K. Pienta, B. Trock, M. Pomper, 2019, The Journal of Nuclear Medicine.

Multi-timepoint imaging with PSMA-targeted [^18F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging

K. Pienta, D. Holt, S. Sheikhbahaei, 2023, Annals of Nuclear Medicine.

Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer.

Martin A Lodge, Eric C Frey, Yinfeng Dong, 2016, Medical physics.

The combination of size‐based separation and selection‐free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer

K. Pienta, Yoon‐Kyoung Cho, W. Xue, 2020, BJU international.

Functional Magnetic Resonance Imaging Response of Targeted Tumor Burden and Its Impact on Survival in Patients With Hepatocellular Carcinoma

Celia P. Corona-Villalobos, T. Pawlik, I. Kamel, 2015, Investigative radiology.

Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.

Celia P. Corona-Villalobos, T. Pawlik, I. Kamel, 2012, Radiology.

Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization.

Benoit Mory, Roberto Ardon, MingDe Lin, 2012, Journal of vascular and interventional radiology : JVIR.

Volumetric RECIST: An Improved Way to Assess Tumor Response after Transcatheter Arterial Chemoembolization (TACE)

J. Geschwind, R. Loffroy, O. Pellerin, 2011 .